ZA201000987B - Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith - Google Patents

Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith

Info

Publication number
ZA201000987B
ZA201000987B ZA2010/00987A ZA201000987A ZA201000987B ZA 201000987 B ZA201000987 B ZA 201000987B ZA 2010/00987 A ZA2010/00987 A ZA 2010/00987A ZA 201000987 A ZA201000987 A ZA 201000987A ZA 201000987 B ZA201000987 B ZA 201000987B
Authority
ZA
South Africa
Prior art keywords
benzothiazol
isoxazol
morpholin
imidazo
ethoxy
Prior art date
Application number
ZA2010/00987A
Inventor
Valeriya N Smolenskaya
Melanie J Roe
Stephen D Parent
Wei Lai
Shripad Bhagwat
Alan Schwartz
Original Assignee
Ambit Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2008/010884 external-priority patent/WO2009038757A2/en
Application filed by Ambit Biosciences Corp filed Critical Ambit Biosciences Corp
Publication of ZA201000987B publication Critical patent/ZA201000987B/en

Links

ZA2010/00987A 2007-09-19 2010-02-10 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith ZA201000987B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94463507P 2007-09-19 2007-09-19
PCT/US2008/010884 WO2009038757A2 (en) 2007-09-19 2008-09-19 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith

Publications (1)

Publication Number Publication Date
ZA201000987B true ZA201000987B (en) 2011-04-28

Family

ID=61026573

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/00987A ZA201000987B (en) 2007-09-19 2010-02-10 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith

Country Status (1)

Country Link
ZA (1) ZA201000987B (en)

Similar Documents

Publication Publication Date Title
IL203926A (en) Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof and uses thereof
SG10201401826TA (en) Formulation comprising metformin and vildagli ptin
IL212308A0 (en) Solid forms of n-(4-(7-azabicyclo[2.2.1] heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide and compositions comprising the same and uses thereof
HK1116088A1 (en) Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
IL190228A0 (en) Phenyl-and pyridyl-1,2,4-oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
LTPA2017031I1 (en) 8 - [{1- (3,5-Bis- (Trifluoromethyl) phenyl) ethoxy} -methyl] -8-phenyl-1,7-diaza-spiro [4.5] decan-2-one hydrochloride salt and the method of its preparation
EG25201A (en) 4-cyclopropyl-1,2,3- thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same
PL2205244T3 (en) Methods of administering n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy-)imidazo-[2,1-b]-[1,3]-benzothiazol-2-yl]-phenyl}urea to treat proliferative disease
EP1932836A4 (en) Isoxazoline-substituted benzamide compound and harmful organism-controlling agent
TW200613479A (en) Coating formulation having improved rheological properties
EP1838165A4 (en) Methods for enhancing the palatability of compositions for consumption by animals
EP1954685A4 (en) Furoxan compounds, compositions and methods of use
EP1978099A4 (en) Antibacterial substance dm0507 and utilization of the same
HK1116482A1 (en) Oxazolidinone derivatives and use thereof as antibiotics
ZA200801896B (en) Slow-release composition, method for the preparation thereof, and use of the same
BRPI0810323A2 (en) "COMBINATION OF 5-CARBOXYLIC PYROLIDONE ACID, USE OF 5-CARBOXYLIC PYROLIDONE ACID, COMPOSITION AND USE"
NZ627631A (en) Benzoheterocyclic compounds and use thereof
EP1885365A4 (en) Treatment of sepsis and inflammation with alpha2a adrenergic antagonists
EP1791423A4 (en) Compositions and methods for the management of hyperproliferative dermatological conditions
WO2007110173A3 (en) Fungicidal active substance combinations
ZA201000987B (en) Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
WO2006091241A8 (en) Inorgano-neutralized calcined kaolins for use in silicone rubber-based formulations
ITMI20040162A1 (en) USE OF POLYAMINOMETHYLPHOSPHONATE AS DISPERSING AGENTS
PL1904490T3 (en) Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl]phenyl) pyridine-3- sulphonamide
WO2006122012A3 (en) Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate